Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Martin Pytela Recipient Title President Life Enthusiast Co-op 711 S Carson Street Suite 4Carson City, NV 89701United […]

Delivery Method: Via Email Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER August 25, 2025 7558 W. Thunderbird Rd. […]

Delivery Method: Via Email Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER August 25, 2025 RE: 710859 Dear Supply […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Josue Carias Recipient Title CEO Mel Honey US 152 Wapiti LoopHyrum, UT 84319-2012United States [email protected] Issuing Office: […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Dana Ullman Recipient Title Owner Homeopathic Educational Services dba Homeopathic Family Medicine 812Camelia Street, Suite CBerkeley, CA […]

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Bingbing Feng My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD 2452 Gillingham CircleThousand […]

Delivery Method: Via Email Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER August 25, 2025 RE: 710151 Dear Privacy […]

Ajovy (fremanezumab-vfrm) Emgality (galcanezumab-gnlm) Nurtec ODT (rimegepant) Ubrelvy (ubrogepant) Vyepti (eptinezumab-jjmr) Hypertension The “Warnings and Precautions”, “Adverse Reactions”, “Patient Counseling Information”, and “Patient Information” sections of […]

Adcetris (brentuximab vedotin) Guillain-Barre syndrome FDA determined that no action is necessary at the time based on available information. Arzerra (ofatumumab)Gazyva (obinutuzumab)Riabni (rituximab-arrx)Rituxan (rituximab)Rituxan Hycela (rituximab […]